These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30980769)

  • 1. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study.
    Wang T; Wang L; Yang H; Lu H; Zhang J; Li N; Guo CB
    J Oral Pathol Med; 2019 Jul; 48(6):491-498. PubMed ID: 30980769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram for risk prediction of malignant transformation in oral leukoplakia patients using combined biomarkers.
    Zhang X; Kim KY; Zheng Z; Bazarsad S; Kim J
    Oral Oncol; 2017 Sep; 72():132-139. PubMed ID: 28797449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
    Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
    BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
    Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
    Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders.
    Cai X; Zhang J; Han Y; Tang Q; Zhang H; Li T
    Oral Oncol; 2021 Dec; 123():105619. PubMed ID: 34818615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
    Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of nomograms for predicting cancer risk in oral leukoplakia and oral lichen planus.
    Adeoye J; Su YX
    Oral Dis; 2024 Jul; 30(5):3039-3051. PubMed ID: 38009867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia.
    Thiem DGE; Schneider S; Venkatraman NT; Kumar VV; Brieger J; Frerich B; Kämmerer PW
    J Oral Pathol Med; 2017 Oct; 46(9):710-716. PubMed ID: 28036153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation rate of oral leukoplakia in the past 20 years: A systematic review and meta-analysis.
    Guan JY; Luo YH; Lin YY; Wu ZY; Ye JY; Xie SM; Li J
    J Oral Pathol Med; 2023 Sep; 52(8):691-700. PubMed ID: 37224426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of oral leukoplakia on the irradiated or nonirradiated mucosa among survivors of head and neck cancer in the papulation where practice of betel nut chewing and cigarette smoking are widespread.
    Yang SW; Lin CY; Lee YS; Huang SM
    BMC Oral Health; 2024 Jul; 24(1):851. PubMed ID: 39061032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
    Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
    J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral leukoplakia: A clinicopathological study and malignant transformation.
    Tovaru S; Costache M; Perlea P; Caramida M; Totan C; Warnakulasuriya S; Parlatescu I
    Oral Dis; 2023 May; 29(4):1454-1463. PubMed ID: 34982498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
    Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
    Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The"Newcastle Nomogram"-Statistical modelling predicts malignant transformation in potentially malignant disorders.
    Goodson ML; Smith DR; Thomson PJ
    J Oral Pathol Med; 2019 Sep; 48(8):662-668. PubMed ID: 31125457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
    Jäwert F; Pettersson H; Jagefeldt E; Holmberg E; Kjeller G; Öhman J
    Int J Oral Maxillofac Surg; 2021 Nov; 50(11):1422-1428. PubMed ID: 33674140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
    Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
    J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
    Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
    Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
    Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of the combination of SMAD4 expression and lymphocyte infiltration in malignant transformation of oral leukoplakia.
    Sakata J; Yoshida R; Matsuoka Y; Nagata M; Hirosue A; Kawahara K; Nakamura T; Nakamoto M; Hirayama M; Takahashi N; Nakashima H; Arita H; Ogi H; Hiraki A; Shinohara M; Nakayama H
    Cancer Med; 2017 Apr; 6(4):730-738. PubMed ID: 28256094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.